Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The myelin proteolipid plasmolipin, forms oligomers and induces liquid ordered membranes in the Golgi apparatus.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Cambridge Healthtech Institute's Third Annual Anti-inflammatories: small Molecules Meeting, April 17(th) - 18(th) 2012, San Diego, USA.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
The Diagnosis and Treatment of Optic Neuritis.
Simvastatin: Multiple Sclerosis.
Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).
Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.
Analysis of tremor in multiple sclerosis using Hilbert-Huang Transform.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Plasmacytoid dendritic cells and autoimmune inflammation.
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study.
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.
Effective communication at the point of multiple sclerosis diagnosis.
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Pages
« first
‹ previous
…
475
476
477
478
479
480
481
482
483
…
next ›
last »